IONS vs OLN · rev $226.6M vs rev $6.54B
Ionis Pharmaceuticals Inc (IONS) versus Olin Corporation (OLN) — a side-by-side from cached financials, not a winner call.
Ionis Pharmaceuticals Inc (IONS) is a biotechnology company listed on NASDAQ.
Olin Corporation (OLN) is a chemicals company listed on NYSE.
Latest reported IONS revenue for 2024-12-31 was $226.6M. Net income was -$104.3M. Revenue was down 30.2% from 2023-12-31 to 2024-12-31. IONS currently screens at market cap $12.28B.
Latest reported OLN revenue for 2024-12-31 was $6.54B. Net income was $105.0M. Revenue was down 4.3% from 2023-12-31 to 2024-12-31. OLN currently screens at market cap $2.62B.
IONS currently screens at market cap $12.28B. OLN currently screens at market cap $2.62B.
Not investment advice. Open the IONS and OLN stock pages for the full models.
Not investment advice.